Oxygen Biotherapeutics Inc., of Morrisville, N.C., dismissed Chris Stern as CEO and chairman of the company, following an internal investigation. Although the circumstances related to the dismissal were not disclosed, the company said Stern will not be paid severance. Michael Jebsen was named interim CEO as he continues serving as chief financial officer and treasurer.